| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.11B | 72.05B | 72.92B | 80.19B | 87.77B | 85.70B |
| Gross Profit | 18.38B | 18.74B | 18.30B | 20.71B | 22.82B | 23.48B |
| EBITDA | 2.27B | 2.16B | 2.15B | 4.87B | 6.71B | 8.24B |
| Net Income | 518.00M | 1.14B | 405.00M | 2.78B | 3.67B | 5.05B |
Balance Sheet | ||||||
| Total Assets | 74.43B | 78.88B | 76.04B | 75.37B | 72.04B | 69.38B |
| Cash, Cash Equivalents and Short-Term Investments | 13.55B | 10.76B | 13.30B | 18.23B | 19.32B | 22.66B |
| Total Debt | 10.21B | 11.31B | 9.51B | 8.74B | 9.22B | 10.43B |
| Total Liabilities | 31.99B | 32.13B | 31.50B | 32.23B | 33.57B | 35.82B |
| Stockholders Equity | 42.44B | 46.74B | 44.54B | 42.93B | 38.26B | 33.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.45B | -3.17B | 405.00M | -1.80B | 4.24B |
| Operating Cash Flow | 0.00 | -630.00M | -1.61B | 1.56B | -530.00M | 5.14B |
| Investing Cash Flow | 0.00 | -3.77B | -2.46B | -1.13B | -1.53B | -1.02B |
| Financing Cash Flow | 0.00 | 1.70B | -951.00M | -1.77B | -2.19B | -1.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥277.47B | 23.96 | ― | 2.18% | 8.08% | -27.93% | |
73 Outperform | ¥2.40T | 16.86 | 15.67% | 1.94% | 8.60% | 10.04% | |
71 Outperform | ¥170.85B | 10.82 | ― | 3.40% | 6.49% | -11.12% | |
70 Neutral | ¥118.98B | 69.00 | ― | 4.78% | 4.15% | -73.12% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥491.93B | 20.37 | 3.68% | 2.35% | 0.70% | 95.26% | |
56 Neutral | ¥26.26B | 24.65 | ― | 3.56% | -1.19% | 181.64% |